Albemarle’s [ALB] share price has fallen a little flat this year. While the stock is up circa 9% in 2021 to trade at $161.23 (as of 23 April), it’s well off the $187.50 hit during intraday trading in early January.
However, the batteries that are going to power the automobile industry’s transition to electric vehicles are going to need lithium. Given the firm’s position as an industry leader in the lithium market, Albemarle’s share price could recharge.
Lithium-carbonate prices have soared this year as the automobile industry makes the switch to electric vehicles. Over the next decade, this demand will only increase. Tesla [TSLA] is eyeballing 20 million EV sales by 2030; that same year Volkswagen [VOWG] wants 25% of its sales to be from EVs, and five years later in 2035 General Motors [GM] aims to stop selling petrol cars altogether.
To meet the automobile sector's ambitious targets, lithium producers will need to expand production, which could be good news for Albemarle's share price.
Wall Street backs Albemarle’s share price
Evercore ISI analyst Stephen Richardson believes Albemarle’s share price still has more upside left in it. On 19 April, the analyst raised his rating on the stock from hold to buy, along with a adding a $200 price target – hitting this would see a 24% upside on Albemarle’s share price as of 23 April’s close. Richardson describes Albemarle – one of the biggest and most diverse lithium producers – as the “800lb gorilla in the lithium market”. Upcoming plans to expand production by 300,000 metric tons could allow it to “take advantage of increasing lithium prices and a tightening demand outlook.”
Further backing came in March from Cowen & Co, which initiated coverage on Albemarle’s share price with an outperform rating, while Loop Capital upgraded its rating from hold to buy.
Albemarle's financials were hit by the COVID-19 pandemic, with net sales coming in at $879.1m in the fourth quarter, an 11.4% drop from the $992.6m seen in the same period last year. Lithium sales came in at $358.6m, down 12.8% from $411.1m year-on-year. For full year 2021, the company expects lithium volumes to increase due to efficiency improvements in North America. Completion of its La Negra and Kemerton expansion projects should lead to greater sales volume by the start of 2022.
“Longer-term, we expect lithium demand to grow in line with greater EV adoption. We are accelerating our lithium growth projects to capitalize on this trend and generate strong investment returns,” Albemarle said in its fourth quarter results.
"We are accelerating our lithium growth projects to capitalize on this trend and generate strong investment returns" - Albemarle Q$ results
For the full year 2021, Albemarle’s is guiding for an adjusted EBITDA of between $810m and $860m, on $3.2bn to $3.3bn of net sales – a rebound that the company describes as “modest”.
The Lithium investment theme
Lithium as an investment theme has been a strong performer on our thematic screener, gaining circa 158% this past year and approximately 9% in the past month (to 23 April’s close).
This bullishness is reflected in Wall Street, where lithium companies have received a string of upgrades. B. Riley’s Lucas Pipes started coverage of Lithium Americas [LAC] at the end of March with a buy rating and CA$25 price target – well above the current share price of CA$17.76 (as of 23 April’s close). Pipes cited a project in Nevada called Thacker Pass where Lithium America will mine for the ore. As most lithium is produced in South America and Australia, a US mine offers benefits such as lower freight rates and sourcing risks.
Along with Albemarle, Evercore ISI analyst Stephen Richardson also upped his target on Livent [LTHM] from $10 to $20, arguing that recent price weakness in the stock could represent a buying opportunity. Livent’s share price has dipped due to rising coronavirus cases in Argentina, where it operates.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.